The Alpha Journal — Men’s Health Reporting

The evidence-backed short list is shorter than the supplement aisle suggests: melatonin, ashwagandha, magnesium, and a newer botanical called corn leaf extract (CLE) all show statistically significant effects on objective sleep metrics in randomized controlled trials.

A UK Biobank study of 26,820 adults found that self-described evening types scored modestly higher on standardized cognitive tests than definite morning types — even after adjusting for age, sleep duration, health conditions, and lifestyle factors.

Visceral fat largely comes back after stopping tesamorelin. The clinical trial data are unambiguous: men who discontinue the protocol regain most of the visceral adipose tissue (VAT) reduction within six months unless they replace the pharmacologic stimulus with something else.

Chronic short sleep is not a productivity trade-off — it is a measurable physiological insult. Meta-analyses tracking more than 1.5 million adults show that sleeping under six hours per night raises all-cause mortality risk by roughly 12%, and the damage runs from cardiovascular…

Most men start a supplement stack chasing one thing — testosterone, libido, or gym performance — and end up discovering effects they never targeted.

Men who use anabolic-androgenic steroids carry a measurable, documented cancer risk that standard screening guidelines were never designed to address.

Methylphenidate (Ritalin) is the more defensible choice if you're weighing these two stimulants for cognitive enhancement — it produces small but measurable gains in recall and sustained attention, with a pharmacological profile that's somewhat less reinforcing than amphetamine.

Lion's mane (Hericium erinaceus) produces measurable but modest benefits for cognition and mood in specific populations — older adults with mild cognitive impairment, and overweight individuals with mood disturbances.

Early clinical trials suggest psilocybin microdosing produces modest improvements in anxiety and quality of life — but the antidepressant signal is weak, expectancy effects are large, and the evidence sits far behind full-dose psilocybin-assisted therapy.

The interventions with the strongest evidence for reducing heart attacks, strokes, and cardiovascular death in men over 40 are, in order: sustained lifestyle change, blood pressure control, statin therapy, and — for men with diabetes or obesity — GLP-1 receptor agonists.

Daily broad-spectrum sunscreen, prescription tretinoin, and niacinamide are the three interventions with the strongest clinical evidence for slowing visible skin aging in men.

Reduced sex drive after 40 is real, common, and treatable — but the supplement industry has built a billion-dollar business on men who don't know the difference between a clinically validated intervention and a marketing claim. Here is what the evidence actually supports.